Cited by 885RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryExtracellular vesicles in disease

In vitro and ex vivo strategies for intracellular delivery

Stewart, Martin P., Sharei, Armon, Ding, Xiaoyun, Sahay, Gaurav, Langer, Robert, Jensen, Klavs F.·2016·Nature

Abstract

Intracellular delivery of materials has become a critical component of genome-editing approaches, ex vivo cell-based therapies, and a diversity of fundamental research applications. Limitations of current technologies motivate development of next-generation systems that can deliver a broad variety of cargo to diverse cell types. Here we review in vitro and ex vivo intracellular delivery approaches with a focus on mechanisms, challenges and opportunities. In particular, we emphasize membrane-disruption-based delivery methods and the transformative role of nanotechnology, microfluidics and laboratory-on-chip technology in advancing the field.

Integrity signals

Registry

Crossref · 10.1038/nature19764

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Difficulties such as a lack of consistent and reliable methods for exosome purification and the efficient encapsulation of large mRNAs into exosomes must be addressed.

    “However, difficulties such as a lack of consistent and reliable methods for exosome purification and the efficient encapsulation of large mRNAs into exosomes must be addressed.”
  • Using exosome-based mRNA delivery systems has several limitations, such as technical difficulties in generating exosomes loaded with RNA.

    “However, using exosome-based mRNA delivery systems has several limitations, such as the technical difficulties in generating exosomes loaded with RNA [91].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stewart, M. P., Sharei, A., Ding, X., Sahay, G., Langer, R., & Jensen, K. F.
Affiliations
  • Massachusetts Institute of Technology (US)
  • Harvard University (US)
  • Oregon State University (US)
Corresponding author
Jensen, Klavs F.
Venue
Nature
Published
2016-10
Volume
538
Issue
7624
Pages
183-192
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2531550383
Cited by
885
References
101
Citations by year
2026: 71 · 2025: 73 · 2024: 89 · 2023: 88 · 2022: 85 · 2021: 110 · 2020: 117 · 2019: 95 · 2018: 91 · 2017: 64 · 2016: 2
FWCI
7.60
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
intracellular delivery, membrane damage, cytosolic delivery, nanotechnology, microfluidics, lab-on-a-chip, genome editing, ex vivo cell therapy, macromolecule delivery, mammalian cells
MeSH terms
Animals, Cell Membrane, Humans, Transfection, Drug Delivery Systems, Nanotechnology, Intracellular Space, Microfluidics, Lab-On-A-Chip Devices, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review